Clinical Trial Update: Intrathecal Tetanus Immunoglobulin to Treat Tetanus [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on intrathecal tetanus immunoglobulin for treating tetanus, spanning Phase 1 and Phase 2, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• intrathecal tetanus immunoglobulin

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Tetanus | Phase 1, Phase 2 | Status: COMPLETED